BAIN CAPITAL INVESTORS LLC - 16 Oct 2023 Form 4 Insider Report for Cerevel Therapeutics Holdings, Inc.

Role
10%+ Owner
Signature
Bain Capital Investors, LLC, By: /s/ Christopher Gordon, Title: Partner
Issuer symbol
N/A
Transactions as of
16 Oct 2023
Net transactions value
+$124,999,986
Form type
4
Filing time
18 Oct 2023, 16:30:09 UTC
Previous filing
06 Jul 2023
Next filing
21 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Purchase $124,999,986 +5,480,052 +9.1% $22.81 65,679,781 16 Oct 2023 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Bain Capital Fund XII, L.P. ("Fund XII") is the sole member of BCPE Perception GP, LLC ("Perception GP"), which is the general partner of BC Perception. Bain Capital Investors, LLC ("BCI") is the manager of Bain Capital Partners XII, LLC ("Partners XII" and, together with BCI, BC Perception, Fund XII and Perception GP, the "Bain Capital Entities"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of the Issuer's common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
F2 On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering.